Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Expert Opinion on Investigational Drugs
|
May 22, 2013
PA-824 , moxifloxacin and pyrazinamide combination therapy for tuberculosis
Rodney Dawson, Andreas Diacon
Journal of Signal Processing Systems
|
March 28, 2022
Automatic Non-Invasive Cough Detection based on Accelerometer and Audio Signals
Madhurananda Pahar, Igor Miranda, Andreas Diacon, et al.
Antimicrobial Agents and Chemotherapy
|
April 2, 2014
Population pharmacokinetic/pharmacodynamic analysis of the bactericidal activities of sutezolid (PNU-100480) and its major metabolite against intracellular Mycobacterium tuberculosis in ex vivo whole-blood cultures of patients with pulmonary tuberculosis
Tong Zhu, Sven O Friedrich, Andreas Diacon, et al.
Infectious Disorders Drug Targets
|
March 17, 2011
Management of adult active tuberculosis disease in era of HIV pandemic, current practices and future perspectives
Jean B Nachega, Bernd Rosenkranz, Gary Simon, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
June 22, 2017
Pulmonary TB: varying radiological presentations in individuals with HIV in Soweto, South Africa
Jesne Kistan, Fatima Laher, Kennedy Otwombe, et al.
Microbiology Spectrum
|
October 26, 2023
Transrenal <i>Mycobacterium tuberculosis</i> DNA in pulmonary tuberculosis patients during the first 14 days of treatment
Irina Kontsevaya, Jan Heyckendorf, Frauke Koops, et al.
The Lancet. Microbe
|
April 9, 2021
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial
Andreas Diacon, Sachiko Miyahara, Rodney Dawson, et al.
Plos One
|
September 25, 2018
C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial
Henrik Aggerbeck, Morten Ruhwald, Søren T Hoff, et al.
The Journal of Antimicrobial Chemotherapy
|
August 5, 2020
Clofazimine pharmacokinetics in patients with TB: dosing implications
Mahmoud Tareq Abdelwahab, Sean Wasserman, James C M Brust, et al.
The Journal of Infectious Diseases
|
April 1, 2024
Safety and Immunogenicity of the H56:IC31 Tuberculosis Vaccine Candidate in Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis: A Phase 1 Randomized Trial
Dereck Tait, Andreas Diacon, Álvaro H Borges, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Expert Opinion on Investigational Drugs
|
May 22, 2013
PA-824 , moxifloxacin and pyrazinamide combination therapy for tuberculosis
Rodney Dawson, Andreas Diacon
Journal of Signal Processing Systems
|
March 28, 2022
Automatic Non-Invasive Cough Detection based on Accelerometer and Audio Signals
Madhurananda Pahar, Igor Miranda, Andreas Diacon, et al.
Antimicrobial Agents and Chemotherapy
|
April 2, 2014
Population pharmacokinetic/pharmacodynamic analysis of the bactericidal activities of sutezolid (PNU-100480) and its major metabolite against intracellular Mycobacterium tuberculosis in ex vivo whole-blood cultures of patients with pulmonary tuberculosis
Tong Zhu, Sven O Friedrich, Andreas Diacon, et al.
Infectious Disorders Drug Targets
|
March 17, 2011
Management of adult active tuberculosis disease in era of HIV pandemic, current practices and future perspectives
Jean B Nachega, Bernd Rosenkranz, Gary Simon, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
June 22, 2017
Pulmonary TB: varying radiological presentations in individuals with HIV in Soweto, South Africa
Jesne Kistan, Fatima Laher, Kennedy Otwombe, et al.
Microbiology Spectrum
|
October 26, 2023
Transrenal <i>Mycobacterium tuberculosis</i> DNA in pulmonary tuberculosis patients during the first 14 days of treatment
Irina Kontsevaya, Jan Heyckendorf, Frauke Koops, et al.
The Lancet. Microbe
|
April 9, 2021
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial
Andreas Diacon, Sachiko Miyahara, Rodney Dawson, et al.
Plos One
|
September 25, 2018
C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: A phase 3 trial
Henrik Aggerbeck, Morten Ruhwald, Søren T Hoff, et al.
The Journal of Antimicrobial Chemotherapy
|
August 5, 2020
Clofazimine pharmacokinetics in patients with TB: dosing implications
Mahmoud Tareq Abdelwahab, Sean Wasserman, James C M Brust, et al.
The Journal of Infectious Diseases
|
April 1, 2024
Safety and Immunogenicity of the H56:IC31 Tuberculosis Vaccine Candidate in Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis: A Phase 1 Randomized Trial
Dereck Tait, Andreas Diacon, Álvaro H Borges, et al.
Page
of 2